Lupin Limited

NSE: LUPIN

Pharma Pharmaceuticals

₹1,939.2

-1.14%EOD · 19 Oct

Lupin Limited is a listed Pharmaceuticals company on NSE/BSE. Detailed profile data is being compiled — check BSE filings for the latest disclosures.

Market Cap

₹88,678 Cr

52W Range

₹2530 / ₹1900

Volume

602K

56.4% delivery

1Y Return

-0.1%

P/E Ratio

16.3

P/B Ratio

4.0

ROE

26.9%

Debt / Equity

29.39

Peers in Pharma

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Lupin Limited(this stock)	₹1,939.2	₹88,678 Cr	16.3	4.0	26.9%	0.91%
Sun Pharmaceutical Industries LimitedSUNPHARMA	₹1,743	₹4.18 L Cr	34.9	5.0	14.7%	0.91%
Cipla LimitedCIPLA	₹1,324.1	₹1.07 L Cr	31.8	3.1	11.7%	0.98%
Dr. Reddy's Laboratories LimitedDRREDDY	₹1,242.5	₹1.03 L Cr	31.0	2.7	8.8%	0.66%

Quality Score

Durability · Valuation · Momentum — objective math, not advice

48/100

Composite score: 40% quality, 30% valuation, 30% momentum

QualityGood · 60

ValuationGood · 60

MomentumPoor · 20

High ROE (26.9%)

High debt load (D/E 29.4)

In confirmed downtrend (Stage 4)

Technical Indicators

Full analysis · objective math, not advice

Returns

-1.1%

+0.2%

-6.9%

-19.4%

-16.0%

-0.1%

Weinstein Stage

Stage 4 — Declining (downtrend)

RSI (14)

30 Neutral

Trend Template

2/7weak

RS vs Nifty (3M)

-14.6pp

Moving Averages (price vs MA)

20-DMA

₹2015

below

50-DMA

₹2102

below

150-DMA

₹2263

below

200-DMA

₹2250

below

From 52W High

-23.3%

From 52W Low

+2.1%

Support (20D)

₹1926

Resistance (20D)

₹2135

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

Quality Signals

Multi-year consistency · Source: Screener annual data

ROE Consistency

0/0 years ≥15%

Revenue Growth

+6.5% CAGR

Up 8 of last 11 years

Earnings Quality

Mostly cash-backed

OCF / Net Profit = 0.87x · 12/12 yrs +ve cash flow

Quality signals derived from multi-year annual financials. ROE consistency = years with ≥15% return on equity. Cash-backed = operating cash flow vs reported net profit (≥1x means earnings are converted to real cash, not just accruals). Educational reference only — not investment advice.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.